Pulmonology

Researchers found that different pets elicit different allergy responses in child participants.

An investigative team is skeptical on the involvement if autonomic nervous function in cases of idiopathic pulmonary fibrosis.

Investigators suggest symptoms in asthmatic patients are more severe, although it does not result in higher mortality rates.

A team of investigators stress the impact of the disease on patients as mortality rates grow worldwide.

The National Institutes of Health expert and research joins to discuss the evolving understanding of vaping devices and effects.

A new Polish study calls for greater focus on asthma and the link to delirium in older patients, who may face greater mortality risk.

A large number of nationwide infection rates in long-term care facilities are a product of seasonal influenza and RSV, according to a new study.

Elexacaftor/tezacaftor/ivacaftor and ivacaftor was previously approved for CF patients at least 12 years old.

An expert discussion on categorizing climate change and the impact it will have on health in communities across the globe.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

The newest findings show the TSLP inhibitor is beneficial over 52 weeks in patients aged 12-80 years old.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

Not all individuals with sarcoidosis need to be treated.

The 2021 annual report finds that Los Angeles remains the most polluted US city, while negative impacts of climate change and COVID-19 are both linked to increased pollution rates.

The monoclonal antibody was linked to significant improvements in endoscopic nasal polyp and nasal obstruction symptom visual analogue scale scores.

A trio of experts from the Cleveland Clinic join Dr. Rizzo for a talk on lung transplant trends and challenges in the US.

Ennis James, MD, discusses the challenges and lingering questions associated with sarcoidosis

The non-invasive device uses air pressure pulsations to help open airways and provide clearance of secretions in patients with disease such as COPD, asthma, and cystic fibrosis.

An interview with a phase 2 investigator on the the novel drug's potential in a field it wasn't originally designed to treat.

New phase 2 data from a 24-week assessment suggest the first-in-class drug could benefit exercise and pulmonary-vascular outcomes.

The supplemental approval for Tyvaso comes on the basis of clinical evidence showing benefit for pulmonary and cardiovascular outcomes in adult patients.

The Harmony Transcatheter Pulmonary Valve System is designed to treat adult and pediatric patients with pulmonary valve regurgitation.

On World TB Day, experts from the ALA and CDC reflect on the recent issues of tuberculosis.

In commemoration of World TB Day, a CDC and ALA expert discuss how TB still exists in the country.